entertainment -WSS

entertainment

author：explore 2025-10-02 17:21:27 - browse：827

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

A group of advisers to the Food and Drug Administration voted in favor of Alnylam Pharmaceuticals’ treatment for a debilitating heart disease Wednesday, but only after a day-long debate challenging whether the drug’s modest observed effects were actually meaningful for patients.

The group of independent experts voted 9-3 that the benefits of Alnylam’s drug, called patisiran, outweighed its risks for patients with ATTR-CM, a progressive disease that leads to fatal heart failure if left untreated. The FDA, which is not required to follow the advice of advisers, is expected to make a final decision on patisiran by Oct. 8.

“It’s like a light wind blowing in favor of patisiran over placebo,” said David Cella, a neurologist at the Northwestern University Feinberg School of Medicine who voted in favor of patisiran. David Moliterno, a cardiologist at the University of Kentucky, added that “the good news in this story is that while there may be a small benefit, it doesn’t look like there’s a signal for harm.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
Next article： Maui wildfire now ranks as the fifth

explore

WSS

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

After Optum profits sink, UnitedHealth makes changes

Timeline: How the deadly wildfires took over Maui day by day

Biogen’s boardroom scandal saddles CEO with first crisis

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

explore

entertainment

entertainment

Activists slam private health insurers over coverage restrictions

Senators push IRS to launch nonprofit hospital probe

As demand for Covid shots wanes, Moderna seeks its next success

Eisai exec who led development of Alzheimer’s drug to retire

In Memoriam: Notable people who died in 2023

Medicare wants to send $9 billion to 340B hospitals

Cancer drug shortages should be causing more outrage

Schizophrenia gene found to be linked to cells' energy dysfunction

Cancer drug shortages should be causing more outrage

Novo Nordisk touts Wegovy study, but still struggling with supply

focus

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Be careful with at

Medicare wants to send $9 billion to 340B hospitals

Mark Cuban is blaming the wrong people for high drug costs

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Wikipedia

explore

Wikipedia

knowledge